{"title":"利用膜定位肽无细胞生产靶向脂质体","authors":"Kaori Kuno, Yasuhiro Shimane, Yuji Sakai, Yutetsu Kuruma","doi":"10.1016/j.jconrel.2025.114343","DOIUrl":null,"url":null,"abstract":"Cell-free protein synthesis technology is a powerful tool for the rapid production of bioactive molecules such as antibodies. By combining with liposomes, immobilizing the synthesized proteins onto the liposome membrane leads production of bioactive liposomes within the cell-free reaction. These cell-free approaches can be applied in medical treatment and drug development, however, not many studies have been done to develop it as a highly versatile platform. Here, we explored hydrophobic amino acid sequences that lead hydrophilic proteins onto the liposome membrane and applied them to the co-translational production of bioactive liposomes. The membrane localizing peptides (MLPs) introduced at the N- or C-terminus of small molecular weight antibodies, nanobody, guided the membrane localization onto liposomes. The nanobodies-decorated liposomes specifically bound to cancer cells expressing the target antigen protein, thus suggesting maintaining functional structure on the liposome membrane. The MLPs we discovered can be widely applied to the rapid immobilization of proteins on liposome surfaces, leading to cell-free applications in virus-like particles or RNA therapy.","PeriodicalId":15450,"journal":{"name":"Journal of Controlled Release","volume":"48 1","pages":""},"PeriodicalIF":11.5000,"publicationDate":"2025-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cell-free production of target-directed liposomes utilizing membrane localization peptides\",\"authors\":\"Kaori Kuno, Yasuhiro Shimane, Yuji Sakai, Yutetsu Kuruma\",\"doi\":\"10.1016/j.jconrel.2025.114343\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Cell-free protein synthesis technology is a powerful tool for the rapid production of bioactive molecules such as antibodies. By combining with liposomes, immobilizing the synthesized proteins onto the liposome membrane leads production of bioactive liposomes within the cell-free reaction. These cell-free approaches can be applied in medical treatment and drug development, however, not many studies have been done to develop it as a highly versatile platform. Here, we explored hydrophobic amino acid sequences that lead hydrophilic proteins onto the liposome membrane and applied them to the co-translational production of bioactive liposomes. The membrane localizing peptides (MLPs) introduced at the N- or C-terminus of small molecular weight antibodies, nanobody, guided the membrane localization onto liposomes. The nanobodies-decorated liposomes specifically bound to cancer cells expressing the target antigen protein, thus suggesting maintaining functional structure on the liposome membrane. The MLPs we discovered can be widely applied to the rapid immobilization of proteins on liposome surfaces, leading to cell-free applications in virus-like particles or RNA therapy.\",\"PeriodicalId\":15450,\"journal\":{\"name\":\"Journal of Controlled Release\",\"volume\":\"48 1\",\"pages\":\"\"},\"PeriodicalIF\":11.5000,\"publicationDate\":\"2025-10-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Controlled Release\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jconrel.2025.114343\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MULTIDISCIPLINARY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Controlled Release","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jconrel.2025.114343","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
Cell-free production of target-directed liposomes utilizing membrane localization peptides
Cell-free protein synthesis technology is a powerful tool for the rapid production of bioactive molecules such as antibodies. By combining with liposomes, immobilizing the synthesized proteins onto the liposome membrane leads production of bioactive liposomes within the cell-free reaction. These cell-free approaches can be applied in medical treatment and drug development, however, not many studies have been done to develop it as a highly versatile platform. Here, we explored hydrophobic amino acid sequences that lead hydrophilic proteins onto the liposome membrane and applied them to the co-translational production of bioactive liposomes. The membrane localizing peptides (MLPs) introduced at the N- or C-terminus of small molecular weight antibodies, nanobody, guided the membrane localization onto liposomes. The nanobodies-decorated liposomes specifically bound to cancer cells expressing the target antigen protein, thus suggesting maintaining functional structure on the liposome membrane. The MLPs we discovered can be widely applied to the rapid immobilization of proteins on liposome surfaces, leading to cell-free applications in virus-like particles or RNA therapy.
期刊介绍:
The Journal of Controlled Release (JCR) proudly serves as the Official Journal of the Controlled Release Society and the Japan Society of Drug Delivery System.
Dedicated to the broad field of delivery science and technology, JCR publishes high-quality research articles covering drug delivery systems and all facets of formulations. This includes the physicochemical and biological properties of drugs, design and characterization of dosage forms, release mechanisms, in vivo testing, and formulation research and development across pharmaceutical, diagnostic, agricultural, environmental, cosmetic, and food industries.
Priority is given to manuscripts that contribute to the fundamental understanding of principles or demonstrate the advantages of novel technologies in terms of safety and efficacy over current clinical standards. JCR strives to be a leading platform for advancements in delivery science and technology.